Ozempic y Wegovy contienen el mismo principio activo (semaglutida), pero en dosis diferentes y con indicaciones distintas
The response is physiological
Updated May 5, 2026
Providers can help monitor progress, address side effects early, and adjust treatment if needed
Biomarker monitoring, including fasting insulin, HOMA-IR, HbA1c, and body composition, is essential for assessing clinical response during a 12-week MOTS-c protocol
17,20 Dietary fatty acids further stimulate GLP-1 secretion via activation of receptors that trigger signaling cascades involving transcription factors such as peroxisome proliferator-activated receptor gamma and liver X receptor, which upregulate GLP-1 expression